Hesperion Opens Office In Russia

To exploit the booming clinical trial sector in Eastern Europe, Swiss contract research organisation (CRO) Hesperion has established a full-spectrum facility in Moscow, Russia. BMI sees this development as further confirmation of the emergence of Russia and neighbouring countries as premier locations for clinical studies, given their large patient populations and low-cost bases. We expect other CROs to follow Hesperion's example and increase their presence in the

To read the full article, please choose one of the following options: